v3.26.1
Taxes on Income (Tables)
 12 Months Ended
Dec. 31, 2025
Taxes on Income [Abstract]  
Schedule of Significant Components of Deferred Tax Assets and Liabilities Significant components of the Company’s deferred tax assets and liabilities are as follows:
   December 31 
   2025   2024 
Deferred tax assets:        
Carryforward tax losses  $7,378   $10,093 
Research and development   262    1,423 
Operating lease liabilities   752    810 
Share-based compensation   3,124    2,500 
Accrued social benefits and other   699    520 
           
Deferred tax assets before valuation allowance   12,215    15,346 
Less - valuation allowance   (11,434)   (14,416)
Total deferred tax assets   781    930 
           
Deferred tax liabilities:          
Operating lease ROU assets  $(675)  $(815)
Other   (106)   (115)
Total deferred tax liabilities   (781)   (930)
           
Net deferred tax assets  $-   $- 
Schedule of Components of Income Before Income Taxes The components of income before income taxes are as follows:
   Year ended December 31, 
   2025   2024   2023 
             
Domestic (Israel)  $11,106   $5,642   $2,610 
Foreign   1,480    1,560    1,285 
Income (loss) before income taxes  $12,586   $7,202   $3,895 
Schedule of Components of Income Tax Expenses

The components of income tax expenses are as follows:

   Year ended December 31, 
   2025   2024   2023 
             
Current:            
Domestic (Israel)  $286   $-   $- 
Foreign   309    234    182 
Total Income tax expenses  $595   $234   $182 
Deferred:               
Domestic (Israel)  $-   $-   $- 
Foreign   -    -    - 
Total Income tax expenses  $595   $234   $182 
Schedule of Reconciliation of Uncertain Tax Benefits

A reconciliation of the beginning and ending balances of uncertain tax benefits is as follows:

   Year ended December 31, 
   2025 
     
Balance at beginning of the year  $- 
Additions for taxes positions   286 
Balance at the end of the year  $286 
Schedule of Reconciliation Income Tax Benefit to Actual Income Tax Expense (Benefit) A reconciliation of the Company’s theoretical income tax benefit to actual income tax expense (benefit) following the adoption of ASU 2023-09 is as follows:
   Year Ended
December 31,		 
   2025 
         
Tax at Israel statutory rate  $2,895    23.0%
Foreign tax effects:   (29)   (0.2)
Change in valuation allowances   (2,617)   (20.8)
Nontaxable or nondeductible items:          
  Share-based compensation   39    0.3 
  Other   23    0.2 
Change in unrecognized tax benefits   264    2.3 
Other   20    0.2 
Effective tax rate  $595    5.0%
A reconciliation of the Company’s theoretical income tax benefit to actual income tax expense (benefit) before the adoption of ASU 2023-09 is as follows:
   Year ended December 31, 
   2024   2023 
         
Income (loss) before income taxes, as reported in the consolidated statements of income (loss)  $7,202   $3,895 
Statutory tax rate in Israel   23%   23%
Theoretical tax expense (benefit)  $1,656   $896 
Increase (decrease) in income taxes resulting from:          
Tax rate differential on foreign subsidiaries   (15)   (25)
Non-deductible expenses and other permanent differences   (328)   654 
Differences in taxes arising from foreign currency exchange, net   218    (81)
Changes in carry forward tax losses and other temporary differences for which valuation allowance was provided   (1,346)   (1,267)
Other   49    5 
Income taxes  $234   $182 
Schedule of Tax Paid

Cash paid for income taxes, net of refunds received, by jurisdiction pursuant to the disclosure requirements of ASU 2023-09 for the year ended December 31, 2025 is as follows:

   Year Ended December 31, 
   2025 
     
Israel  $21 
U.S.     
   U.S. federal   297 
   U.S. state   33 
Total U.S.   330 
India   132 
Other   2 
Effective tax rate  $485